UPDATED Mar 20, 2023
Companies with a Future performance score of at least 3, ordered by Future performance score.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
STXShield Therapeutics | UKĀ£0.062 | -9.5% | -67.8% | UKĀ£34.4m | n/a | PS11.2x | E78.7% | n/a | ||
AZNAstraZeneca | UKĀ£107.90 | 1.0% | 12.1% | UKĀ£167.2b | UKĀ£129.81 | PE62.4x | E24.4% | 2.1% | ||
INDVIndivior | UKĀ£13.93 | -2.9% | 3.6% | UKĀ£1.9b | UKĀ£23.62 | PS2.6x | E35.2% | 0% | ||
GNSGenus | UKĀ£28.82 | 1.8% | -4.2% | UKĀ£1.9b | UKĀ£42.36 | PE54.6x | E29.4% | 1.1% | ||
ABCAbcam | UKĀ£12.26 | -3.1% | -25.7% | UKĀ£2.8b | UKĀ£15.78 | PE384.5x | E36.7% | 0% | ||
HVOhVIVO | UKĀ£0.16 | -6.0% | 12.5% | UKĀ£105.7m | n/a | PS3x | E52.0% | n/a | ||
ERGOErgomed | UKĀ£10.20 | -4.3% | -19.4% | UKĀ£514.1m | UKĀ£14.45 | PE38.5x | E13.6% | n/a | ||
EAHECO Animal Health Group | UKĀ£1.03 | -9.7% | -33.9% | UKĀ£69.4m | UKĀ£2.05 | PE55.1x | E39.6% | 0% | ||
DPHDechra Pharmaceuticals | UKĀ£25.52 | -0.2% | -39.5% | UKĀ£2.9b | UKĀ£37.81 | PE72.5x | E21.2% | 1.8% | ||
APHAlliance Pharma | UKĀ£0.58 | -12.9% | -48.3% | UKĀ£311.0m | n/a | PE25.5x | E19.0% | 3.0% | ||
BVXPBioventix | UKĀ£37.00 | -2.2% | 11.8% | UKĀ£193.0m | UKĀ£43.00 | PE25.1x | E4.6% | 4.1% |